Together we are stronger

Pharma
to the World

Sharing a commitment
to patients worldwide

Licensing and
Partnership

Turning our services into your solutions

CDMO Services

Driven by innovation

Innovation and
Technology

Face-to-face or virtually

Meet us
around the World

Pharma
to the World

“Opening doors worldwide and giving patients access to new treatments is a rewarding goal. Country by country, product by product this goal is materialized through our key partnerships, our trusted network with shared common values. Salvat International will continue building key bridges to reach more patients.”

Patricia Ferriot, International & Business Development Director

Pharma to the World

Together we are stronger

Salvat develops, manufactures, and markets innovative products with the aim of fulfilling unmet needs with the help of its global partners while also offering CDMO services. Our constant growth wouldn’t be possible without a large network of top-tier international partners with whom we share the same commitment: putting the patient at the center.

INTERNATIONAL BUSINESS ACTIVITIES

Licensing our products worldwide

Providing solutions through our CDMO services

Licensing and Partnership

Sharing a commitment to patients worldwide

LICENSING OUT

We establish strategic alliances with partners who share our passion for innovation and our vision of contributing to a healthier and happier life for people. We grant licenses for our in-house products worldwide.

OTORHINOLARYNGOLOGYOPHTHALMOLOGYGASTROENTERLOLOGYCONSUMER HEALTH CARE
Cetraxal ®
Cetraxal ® Plus
Saletego ®
Ekzem ®
Audiovit ®
Tinnitan ® Duo
Nasolina ®
Tebarat ® Nasal
Bimeox ®
Tanolux ®
Cetraflux ®
Ursitan ®
Tebarat ®
Relive Sicca ®
Relive ® Total Care
Relive ® Night
Relive ® Dry Eye
Nurane ®
Nurane ® Retina
Monolitum ®
Monolitum ® Flas
Salvacolina ® Flas
Megasmect ®
Nutira ®
Cristalmina ®
Herpix ®
Vincicalm ®
Vincigrip ®
Urosens ®
Urosens ® Forte
Urosens ® Manosa

60+ COUNTRIES 280+ MARKETING AUTHORIZATIONS

Product Pipeline

We focus on three therapeutic areas: otolaryngology, ophthalmology, and gastroenterology, while also keeping an eye on the local OTC market. Our goal is to develop products that improve convenience and compliance, therefore improving patient quality of life.

Check our Product Pipeline

Click here

LICENSING IN

For over 69 years, Salvat has been marketing branded pharmaceutical products with its own commercial capabilities with successful results. Market-specific sales forces: Rx and OTC, in Spain and Portugal. Focused on Ophthalmology, Otorhinolaryngology, Gastroenterology, Wound Care and Consumer Health Care.

WHY PARTNER WITH US?

CURRENT PARTNERS SELECTION

CDMO Services

Turning our services into your solutions

Salvat provides an integrated and tailored end-to-end solutions to ensure the commercial success of your project.

We own the latest technologies as well as a wide expertise in insoluble and high potency drug from early development to commercial manufacturing of drug products.

WE ARE EXPERTS IN STERILE LIQUIDS: SINGLE DOSE AND MULTIDOSE VIALS

CONTRACT DEVELOPMENT

Salvat proposes solutions tailored to customer needs using its technology platforms and know-how acquired from years of experience. We have an expert, integrated team to help you bring your ideas to market in the form of new developments, product lifecycle management, or generics.

– Pre-formulation

– Formulation

– Analytical development and validation

– Clinical batch supply

– Design, validation and packaging process

Find more information at: Technology & Innovation

CONTRACT MANUFACTURING

When it comes to the success of your product, we understand the importance of excellent logistics, regulatory compliance, quality, and good manufacturing practices, in addition to the experience to back it all up. These components, paired with strong packaging capabilities, allow us to offer you a complete service.

Salvat has different dosage forms and packaging, including Blow-Fill-Seal technology (single-dose vials), multidose sterile and non-sterile, tablets, capsules, and sachets.

The production facilities provide analytical method validation, stability studies, manufacturing pilot, clinical trial, and commercial-scale batches with the latest technology.

Find more information at: Technology & Innovation

DOSE FORMS AND PACKAGING CAPABILITIES

SOLIDS

DOSAGE FORM

Dry & Wet Powders
Blending Powders
Dry & Wet Granulation
Pellets
Tableting
Tablet Coating
Sugar Coated Tablets
Oral Dispersible Tablets
Hard Gelatin Capsules
(powders & pellets)

PACKAGING

Sachets
Push-through packs:
ALU/PVC
ALU/PVDC
ALU/TRIPLEX
ALU/ALU

Peel-off blister:
ALU/ALU

SEMISOLIDS

DOSAGE FORM

Gels
Creams
Film

PACKAGING

Tube

LIQUIDS

DOSAGE FORM

Solutions
Nano-emulsions
Emulsions
Suspensions
Syrups
Lotions

PACKAGING

Multi-dose bottle
Multi-dose sterile
Unit dose vials
(Blow-Fill-Seal)
Sprays
Nebulizer

We have manufacturing facilities in Barcelona, Madrid, and Tamarac (Florida) with the capacity to produce sterile and non-sterile liquids, semi-solids, and solids.

Check our Manufacturing sites map

Click here

Innovation and Technology

Driven by innovation

Developing new, innovative drug formulations represents a new challenge as industry product innovation advances faster than ever before. At Salvat, we can help you to overcome these challenges. Thanks to our technology and more than 69 years of experience, we can provide you with a custom solution that is adapted to your needs.

DEVELOPMENT TECHNOLOGY

Nanoemulsion and Smart Polymer Technology Platforms

Solutions for Ophthalmic, Nasal and Otic Drug Delivery Systems Enhanced drug delivery provides:

– Longer residence time
– Lower frequency of administration
– Lower doses required
– Fewer side effects (local and systemic)
– Improves patient adherence and compliance

Oral Multiparticulate Technology Platforms

Solutions for Oral Multiparticulate Drug Delivery Systems. Able to provide a Drug Delivery Toolbox, with “On Demand” oral drug release profiles:

– Multiple pulses
– Gastro-resistant
– Extended-release

PACKAGING TECHNOLOGY

Blow-Fill-Seal Technology
Solutions & Nanoemulsions

ADVANTAGES

Innovative format = Differentiation
Single-dose vials = Increased patient compliance
Preservative free dosing = Better tolerability
100% leak test inspection
Fully sterile manufacturing process

TECHNICAL SPECIFICATIONS

– 5 Blow-Fill-Seal lines (Rommelag technology)
– Over 250 M unit ampoule capacity/year
– Fill volume range from 0.20 ml to 15 ml
– Batch size from 50 L to 2000 L

Multi-dose Sterile
Solutions & suspensions

ADVANTAGES

Innovative multiple formats = Differentiation
Preservative free* = Better tolerability
Sterile by filtration in solutions (not irradiated)
Fully sterile process

Specific container to prevent contamination after opening*

TECHNICAL SPECIFICATIONS

– Sterile bottle filling line (Groninger technology)
– Over 25 Mio/year
– Fill volume range from 2 ml to 10 ml
– Batch size 50 L – 2000 L
– ATEX formulation capabilities

Non-Sterile Multi-dose Liquids
Nanoemulsions, Solutions, Suspensions

ADVANTAGES

Wide range of application devices available
Automated filling technology provides high output, and little set up between products
Flexibility, quick set up and versatility

TECHNICAL SPECIFICATIONS

– Over 23 Mio/year
– Fill volume range from 0.20 ml – 3 ml
– Batch size 50 L – 2000 L
– Robotic filling under laminar flow
– ATEX area
– Serialization capable

Tablets, Capsules and
Sachets

ADVANTAGES

Easy to carry
Automated line

TECHNICAL SPECIFICATIONS

– Tablets are over 195 Mio/year, capsules 100 Mio/year & Sachets 2.6 Mio/year
– Tablets & Capsules Batch size 100 – 500 kg / Sachets 50 -250 kg
– Tablets coated and uncoated
– Serialization & aggregation capability

Meet Us

Around the World

If you are interested in licensing our products or would like more information on how we can support the development and manufacturing of your product, please fill out the form and we will get in touch with you.

EVENTDATELOCATION
Ophthalmic Drug Delivery Summit24 – 26 January, 2023San Francisco, USA
DUPHAT 202310 – 12 January, 2023Dubai, UAE / Online
PharmaSynergy 202323 – 24 Februrary, 2023 / TBC Online dateBarcelona, Spain / Online
EuroPLX8120 – 21 March, 2023Cascais, Portugal
Bio-Europe Spring 202320 – 22 March, 2023 / 20 – 30 March DigitalBasel, Switzerland / Online
DCAT Week20 – 23 March, 2023New York, USA
Pharma Contract Manufacturing28 – 30 March, 2023Berlin, Germany
ARVO 202323 – 27 April, 2023New Orleans, USA
BePharma24 – 25 April / 02 – 04 May OnlineMexico DF, Mexico
CPhI North America25 – 27 April, 2023Philadelphia, USA
Pharmavenue22 – 23 May, 2023Madrid, Spain
EuroPLX8212 – 13 June, 2023Noordwijk, Netherlands
BIO International Convention5 – 8 June, 2023Boston, USA
CPhI Worldwide, Barcelona24 – 26 October, 2023Barcelona, Spain

View Profile

Follow Us

On Social Media

Join our community and stay up to date on the latest news on the industry, Salvat licensing, and services.

Contact

Salvat International Division

If you are interested in licensing our products or would like more information on how we can support the development and manufacturing of your own product, please fill out the form and we will get in touch with you.

Licensing Products
CDMO Services

FOR MORE INFORMATION
PLEASE CONTACT US